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Abstract
Background—Skin trauma may play a role in the development of morphea lesions. The
association between trauma and the distribution of cutaneous lesions has never been examined.
Objective—Determine whether patients enrolled in the Morphea in Adults and Children (MAC)
cohort exhibit skin lesions distributed in areas of prior (isotopic) or ongoing (isomorphic) trauma.
Methods—Cross-sectional analysis of the MAC cohort.
Results—Of 329 patients in the MAC cohort, 52 (16%) had trauma associated lesions at the
onset of disease. Patients with lesions in an isotopic distribution had greater clinical severity as
measured by a clinical outcome measure (mean modified Rodnan Skin Score of 13.8 vs. 5.3,
P=0.004, 95% CI=3.08-13.92) and impact on life quality (mean Dermatology Life Quality Index
8.4 vs. 4.1, P=0.009, 95% CI 1.18-7.50) than those with an isomorphic distribution. Most frequent
associated trauma were chronic friction (isomorphic) and surgery/isotopic.
Limitations—Recall bias for patient reported events.
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Conclusion—Sixteen percent of patients in the MAC cohort developed initial morphea lesions
at sites of skin trauma. If these findings can be confirmed in additional series, they suggest that
elective procedures and excessive skin trauma or friction might be avoided in these patients.
Keywords
Morphea; localized scleroderma; Morphea in Adults and Children cohort; skin trauma; DLQI;
mRSS
Introduction
Morphea (localized scleroderma) is a heterogeneous sclerosing disorder of the skin and
subcutaneous tissue of uncertain pathogenesis. Several case reports and series have reported
precipitating events including friction from clothing, injection, herpes zoster infection, and
radiation therapy prior to the onset of morphea.1-4 However, the association of morphea with
skin trauma has not been systematically investigated.
Prior reports in morpheaform chronic graft-versus-host disease (GVHD), a disorder
clinically similar to morphea, indicate that these lesions may be distributed in areas of skin
trauma and have used the terms isotopic and isomorphic to describe the distribution of these
lesions.5, 6 The isotopic response is defined as the development of a second, unrelated
disease in the same area as previous healed disease or injury (Figure 1).6 This is in contrast
to the isomorphic response of Koebner, which describes skin lesions appearing in areas of
repeated trauma (Figure 2).5 Given that there is an association between skin trauma and the
distribution of skin lesions in morpheaform GVHD, it is reasonable to expect this may also
be true in morphea. Determining whether there is an association between morphea and skin
trauma has important implications for both pathogenesis and clinical care.
The Morphea in Adults and Children (MAC) cohort was designed to examine demographic,
clinical, and autoimmune features of adults and children with morphea. Following patients
prospectively, we aimed to define the effect of these features on clinical outcomes. The
objective of this study was to determine the frequency of the presence of lesions distributed
in sites of skin trauma (in an isotopic or isomorphic distribution) in patients enrolled in the
MAC cohort. We also examined patient demographics, clinical characteristics, and impact
on quality of life in patients with trauma-induced morphea lesions.
Methods
Patients
The institutional review board-approved Morphea in Adults and Children (MAC) cohort
contained 329 adults (18 years or older at enrollment) and children (≤17 years old at
enrollment) as of March 2012. Patients were prospectively recruited from within the
University of Texas Southwestern Medical Center system and from private practitioners
providing patients of varied disease severity, subtypes, and socioeconomic backgrounds.
Criteria for inclusion in this study included: eligibility for enrollment in the MAC cohort,
age four years or older at time of enrollment, the presence of sufficient information for
analysis, an inciting traumatic event at the initial site of morphea, and the presence of trauma
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induced lesions. The latter two variables were obtained from the predetermined Case Report
Form (CRF) which specifically queried patients for any skin trauma occurring in the site of
their lesions prior to disease onset. If patients answered “yes” further inquiries were made
including questions regarding the type of traumatic event and the location and timing of the
event in relation to the morphea onset and location of the initial lesion. In addition, the site
was examined by one author (HJ) to ascertain residua of trauma (surgical scar, radiation
markings, scar from trauma, etc.) Medical records were obtained for verification of date and
type of procedure. In cases of radiation therapy related to morphea lesions, biopsies were
performed to exclude cutaneous metastasis and radiation induced dermatitis. Isotopic
patients were defined as those who had trauma occur at the site of the initial lesion within 6
months of onset of morphea with confirmation by medical records and/or physical
examination. Isomorphic patients were those with lesions distributed exclusively in areas of
friction in the brassiere, waistband, and inguinal crease. These classifications were based on
definitions in the literature5, 6 and recent studies of sclerotic-type GVHD.7, 8
Variables of Interest
Data was collected using a CRF that included demographic, clinical, medical history,
Dermatology Life Quality Index (DLQI), and physician-based determinants of disease
severity --modified Rodnan Skin Score (mRSS) and Localized Scleroderma Cutaneous
Assessment Tool (LoSCAT).9, 10 The mRSS was included because the Localized
Scleroderma Cutaneous Assessment Tool (LoSCAT) was not available at the inception of
the cohort and is the only clinical score available for all MAC cohort patients. Medical
records were obtained and reviewed for confirmation of patient reported findings including
any reported skin trauma. All patients were examined by one examiner with significant
expertise in morphea (HJ), who assigned the subtype and scores. Clinical classification was
based on the preliminary proposed criteria established by Laxer and Zulian into linear,
plaque, and generalized subtypes.11 The linear subtype was defined as a linear induration
affecting the dermis and may include the subcutaneous tissue and underlying muscle.
Generalized morphea is indurated plaques that have become confluent on at least two
anatomic sites whereas plaque morphea is an indurated plaque that has not become
confluent.
Quality of Life
Disease-related quality of life over the preceding 7 days was measured with the 10-item
validated DLQI (range 0-30, with 30 reflecting greatest effect). Scores were divided into
categories: 0-1 = no effect, 2-5 = small effect, 6-10 = moderate effect, 11-20 = very large
effect, and 21-30 = extremely large effect from their skin disease.12 Itching and pain were
assessed on a visual analog scale (VAS)13 of 1-10, with 10 indicating greatest severity.
Statistical Analysis
In this cross-sectional study, the association with all outcomes of interest was compared
between the trauma induced groups (isomorphic and isotopic) as well as the overall MAC
cohort. Fisher's exact test was used for comparisons of categorical variables and an unpaired
t-test was used for comparisons of continuous variables between groups with P values < 0.05
considered significant. Means along with confidence intervals were calculated for
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continuous variables. GraphPad (GraphPad Software Inc, La Jolla, CA) was used for all
analyses.
Results
Of the 329 patients in the MAC cohort, a total of 52 (16%) met the inclusion criteria -- 21
(6%) isotopic and 31 (9%) isomorphic. Patients (n=277) were excluded from the study due
to the following: age <4 years (n=9), insufficient data on variables of interest (n=29),
indeterminate subtype (n=8), and lack of inciting event or isomorphic distribution of lesions
(n=231). The demographics of the patients included in the study are shown in Table I. The
mean age of onset for the isotopic group was 44.4 versus a mean age of 52.4 in the
isomorphic group (P=0.1). Both groups were female predominant (86% of the isotopic
group and 100% of the isomorphic were female).
In comparing the trauma-induced morphea group (both isotopic and isomorphic) with the
overall MAC cohort, the trauma-induced group had a mean age of 49.13 (9 -78) when
compared with the overall cohort 30.4 (0.2 – 78) (p<0.0001). Of the trauma-induced
morphea patients 87% presented with the generalized subtype in contrast to the MAC cohort
in which patients presented with the following subtypes: 52% linear, 33% generalized, and
14% plaque. Relative to the MAC cohort overall, children were underrepresented in the
trauma induced group (4/52% vs. 92/329%). The trauma-induced group also had a higher
mean mRSS of 6.7 (5.1 - 8.3) compared to 6.0 (5.4 - 6.6) in the overall MAC cohort, but this
difference was not statistically significant (P=0.47). Both groups had similar DLQI scores
with 5.98 (4.39 - 7.57) for the trauma-induced group and 6.06 (5.30-6.82) for the overall
MAC cohort (P=0.93).
The morphea subtypes, clinical features, and autoimmune associations are shown in Table
II. In both groups, the majority of patients had generalized morphea -- 71% isotopic and
97% isomorphic however the isomorphic group had a statistically higher proportion of
generalized and a lower proportion of linear morphea than the isotopic group (P=0.02).
Patients with isotopic morphea had increased disease severity when compared to the
isomorphic group with a mRSS of 9.8 versus 5.3, respectively (P=0.01). Additionally
patients with isotopic morphea had a decreased QoL as shown in the DLQI with a score of
9.1 versus 4.1 for the isomorphic group (P=0.002). Despite differences in QOL, both
trauma-induced groups reported similar symptoms of itch and pain with isotopic patients
reporting a mean of 4.7 (3.0 – 6.4) and 3.7 (2.1 – 5.2) on the VAS respectively compared to
4.3 (3.0 – 5.7) and 2.8 (1.8 – 3.8), (P=0.74 and P=0.30) for the isomorphic patients. Both
trauma induced groups had an equal proportion of positive ANA patients (P=1).
The putative inciting events in isotopic patients are provided in Table III. Previous surgeries
were the most common antecedent events prior to the development of lesions. Surgical
procedures performed on patients in this cohort included mastectomy, lumpectomy, breast
augmentation, gastric bypass, rhinoplasty, coronary artery bypass surgery, and arthroplasty.
Penetrating trauma, injections, and radiation were less frequent. Of note, the majority of
these lesions occurred in the chest or in the case of women, breasts (Table IV).
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Discussion
The objective of this cross-sectional study was to determine the frequency of skin trauma-
associated lesions in the MAC cohort and the associated demographic and clinical features
in these patients. We found that of 329 patients, 52 (16%) had evidence for skin trauma or
friction in the clinical distribution of skin lesions at the onset of disease. This was present
most frequently in adults with the subtype of generalized morphea (Table II) implicating the
possibility of an isotopic/isomorphic response in the pathogenesis of these lesions.
Although the prevalence of trauma-induced lesions was not previously assessed in a
prospective cohort of morphea patients, our results are consistent with prior case reports and
case series suggesting friction from clothing, injection, herpes zoster infection, and radiation
therapy in the development of morphea lesions.1-4 Similar associations are reported in other
sclerosing skin conditions including systemic sclerosis and morpheaform cGVHD. Sclerotic
type cGVHD has been shown to occur in an isotopic fashion with ionizing radiation,
repeated needle sticks, and varicella-zoster virus infection as well as in an isomorphic
fashion at areas of skin friction (waistband and brassiere line).7, 8 As seen in Table IV,
greater than 40% of patients with trauma induced lesions had them on the breast implying a
potential preferential distribution, however its significance is difficult to ascertain due to the
strong female predominance of affected patients who would be more likely to have
procedures in those areas. Also of interest, children, in which the subtype is predominantly
linear, were underrepresented in the trauma induced morphea group relative to the overall
MAC cohort. This implies trauma may be a less important factor in pathogenesis in children,
although further study is needed. In addition, the isotopic patients had a higher MRSS and a
lower mean number of body sites affected implying increased induration of these lesions,
however this was not supported by the LoSDI scores. Further research is needed to
determine the difference in induration of lesions.
The results of the present study suggest the possibility of an isotopic or isomorphic response
in morphea. The underlying mechanism has yet to be defined, but studies in the
pathogenesis of fibrosis have shown that tissue damage from recurrent or sustained trauma
upregulates damage-associated endogenous toll-like receptor ligands. In turn, this activates
fibroblast innate immune signaling which enhances fibrinogenic responses and establishes a
self-amplifying cycle of fibrogenesis.14 Additionally, patients with scleroderma have
reduced or defective intrinsic protective signals such as peroxisome proliferator-activated
receptor – gamma (PPAR-gamma) which acts as a brake on fibroblast activation.14 These
findings support current hypotheses for the role of aberrant wound healing and stress in the
development of fibrosis, as well as provide insight into the pathogenesis of morphea in this
patient cohort.
Conclusions from the present study are limited by a small sample size particularly when
dividing trauma into isomorphic and isotopic subgroups. In addition, despite concerted
efforts to document trauma and the development of skin lesions, we had to rely on patient
report for the timing of the onset of morphea related to trauma.
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The present study found a clear association between trauma and morphea at the site of
antecedent injury in a relatively sizable proportion of morphea patients, suggesting the
possibility of an isotopic or isomorphic response. If these findings can be confirmed in
additional series, they suggest that elective procedures and excessive skin trauma or friction
might be avoided in these patients.
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CRF Clinical Report Form
DLQI Dermatology Life Quality Index
GVHD Graft-Versus-Host Disease
HJ Heidi Jacobe, MD, MSCS
LoSCAT Localized Scleroderma Cutaneous Assessment Tool
LoSSI Localized Scleroderma Skin Severity Index
LoSDI Localized Scleroderma Skin Damage Index
MAC Morphea in Adults and Children cohort
mRSS Modified Rodnan Skin Scores
VAS Visual Analog Scale
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Figure 1.
Isotopic morphea on the right leg. The solid arrow points to a surgical scar where the lesion
began.
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Figure 2.
a: Isomorphic morphea in the brassiere line of a Caucasian female undergoing phototherapy
b: Isomorphic morphea in the waist band and inguinal areas in the same patient.
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Table II
Secondary characteristics: morphea subtype, clinical features, and autoimmune
associations
Trauma induced morphea
P valueIsotopic Isomorphic
Mean MRSS (SEM), n 9.8 (2.4), 13 5.3 (0.5), 30 0.01
LoSCAT, n 8 17
 Mean LoSSI (SEM) 45.9 (18.3) 24.6 (4.8) 0.14
 Mean LoSDI (SEM) 24.4 (9.4) 20.2 (3.4) 0.61
Mean DLQI (SEM), n 9.1 (1.7), 21 4.1 (0.6), 31 0.002
Itching, mean (SEM) 4.7 (0.8), 21 4.3 (0.7), 31 0.74
Pain, mean (SEM) 3.7 (0.7), 21 2.8 (0.5), 31 0.30
Mean # of sites (SEM) 7.7 (1.7) 9.3 (0.9) 0.38
ANA, n (%) 1
 Positive ANA 3 (25) 5 (23)
 Negative ANA 9 (75) 17 (77)
Concomitant autoimmune, n (%) 7 (33) 12 (39) 0.77
Morphea subtype, n (%) 0.02
 Linear 4 (19) 0 (0)
 Plaque 2 (10) 1 (3)
 Generalized 15 (71) 30 (97)
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Table III
Putative inciting events in patients with isotopic morphea
Inciting event Patients, n (%)
Surgery 9 (43%)
Penetrating trauma 4 (19)
Injection 3 (14)
Herpes Zoster 2 (10)
Radiation therapy 1 (5)
Diagnostic x-ray 1 (5)
Extreme exercise 1 (5)
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Table IV
Distribution of Morphea Lesions
Trauma induced morphea
Isotopic Isomorphic
Abdomen (%) 3 (14) 26 (57)
Arms (%) 2 (10) 0 (0)
Chest (%) 10 (48) 20 (43)
Face (%) 4 (19) 0 (0)
Lower Back (%) 1 (5) 0 (0)
Legs (%) 1 (5) 0 (0)
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